Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
| (Q1)Jan 31, 2026 | (FY)Oct 31, 2025 | (Q4)Oct 31, 2025 | (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 58.18%-254.95K | -53.02%-2.03M | -582.29%-776.58K | 56.70%-229.74K | 30.56%-417.51K | -70.24%-609.59K | 8.07%-1.33M | 161.02%161.02K | -87.51%-530.55K | -16.74%-601.3K |
| Net income from continuing operations | -11.47%-745.95K | -19.68%-3.22M | -136.50%-756.87K | 25.65%-611.31K | -37.19%-1.18M | 2.44%-669.22K | -12.12%-2.69M | -58.45%-320.03K | -155.04%-822.24K | 30.44%-859.53K |
| Operating gains losses | 568.14%18.88K | -95.85%535 | -2,889.12%-37.43K | -153.31%-4.72K | 535.99%39.86K | -76.16%2.83K | 95.75%12.9K | 142.21%1.34K | -77.43%8.85K | 78.92%-9.14K |
| Depreciation and amortization | 141.48%28.53K | 168.21%84.39K | 249.64%37.37K | 203.68%22.45K | 81.89%12.75K | 85.45%11.81K | 36.64%31.46K | 299.66%10.69K | -55.98%7.39K | 21.71%7.01K |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | 104.23%165.67K | --165.67K | --0 | --0 |
| Unrealized gains and losses of investment securities | --0 | -110.69%-13.67K | -248.19%-20.3K | --0 | -44.02%5.97K | -99.23%663 | 7,971.51%127.91K | 132.20%13.7K | 151.30%17.48K | -51.93%10.66K |
| Remuneration paid in stock | 59.00%205.57K | 45.82%1.13M | 56.29%208.33K | 56.29%208.32K | 67.33%585.53K | -18.90%129.29K | -9.17%775.94K | 185.54%133.3K | --133.3K | -50.75%349.92K |
| Other non cashItems | 3.00%33.18K | 3.00%128.87K | 3.00%32.22K | 3.00%32.22K | 3.00%32.22K | 3.00%32.22K | 19.13%125.12K | -57.97%31.28K | 206.67%31.28K | 206.67%31.28K |
| Change In working capital | 274.80%204.84K | -223.90%-148.45K | -291.80%-239.89K | 32.01%123.29K | 164.88%85.33K | -456.70%-117.18K | 202.50%119.82K | 194.79%125.07K | 1,178.52%93.4K | -964.43%-131.51K |
| -Change in receivables | -33.17%97.06K | 153.56%59.63K | 29.12%-56.69K | -50.57%-77.4K | 240.50%48.48K | 166.20%145.23K | 37.22%-111.32K | 53.79%-79.97K | -2,794.26%-51.4K | -3,567.74%-34.5K |
| -Change in prepaid assets | -217.12%-18.25K | -693.84%-28.34K | -26.53%-70.79K | 82.80%21.56K | -69.31%5.31K | -33.07%15.58K | 94.55%-3.57K | 10.02%-55.94K | 203.15%11.79K | 1,392.75%17.3K |
| -Change in payables and accrued expense | 145.33%126.03K | -176.58%-179.74K | -143.07%-112.41K | 34.68%179.13K | 127.59%31.54K | -517.97%-278K | 86.29%234.71K | 152.70%260.99K | 548.33%133K | -975.27%-114.3K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 58.18%-254.95K | -53.02%-2.03M | -582.29%-776.58K | 56.70%-229.74K | 30.56%-417.51K | -70.24%-609.59K | 8.07%-1.33M | 161.02%161.02K | -87.51%-530.55K | -16.74%-601.3K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 9.09%-587.23K | -19.01%-2.52M | 47.14%-615.62K | -66.02%-727.19K | -140.75%-528.32K | -120.48%-645.98K | -91.46%-2.12M | -122.42%-1.16M | -147.04%-438.01K | 23.16%-219.45K |
| Capital expenditure reported | ---- | ---- | ---- | ---- | -124.38%-485.86K | -129.07%-643.65K | -78.19%-1.96M | -109.55%-1.09M | -108.95%-370.48K | 24.18%-216.54K |
| Net PPE purchase and sale | -1,327.23%-33.18K | 73.44%-40.56K | 146.40%32.59K | 57.99%-28.37K | -1,357.47%-42.46K | 80.62%-2.33K | -4,377.65%-152.69K | -5,137.73%-70.24K | ---67.54K | ---2.91K |
| Net investment purchase and sale | --25.86K | --13.31K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other investing changes | 9.90%-579.91K | -26.88%-2.49M | 39.56%-661.51K | -88.63%-698.82K | -124.38%-485.86K | -129.07%-643.65K | -78.19%-1.96M | -109.55%-1.09M | -108.95%-370.48K | 24.18%-216.54K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 9.09%-587.23K | -19.01%-2.52M | 47.14%-615.62K | -66.02%-727.19K | -140.75%-528.32K | -120.48%-645.98K | -91.46%-2.12M | -122.42%-1.16M | -147.04%-438.01K | 23.16%-219.45K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -2.95K | -34.08%2.95M | 250.61%2.35M | -83.46%568.4K | 30K | 0 | 18.47%4.48M | -72.93%671K | 3.44M | 0 |
| Net issuance payments of debt | ---2.95K | ---11.09K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net common stock issuance | ---- | -33.27%2.99M | 256.37%2.39M | -83.48%568.4K | --30K | --0 | 17.89%4.48M | -73.16%671K | --3.44M | --0 |
| Net other financing activities | ---- | -818.87%-27.57K | ---- | ---- | ---- | ---- | 85.67%-3K | --0 | ---3K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---2.95K | -34.08%2.95M | 250.61%2.35M | -83.46%568.4K | --30K | --0 | 18.47%4.48M | -72.93%671K | --3.44M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -46.23%1.86M | 42.55%3.46M | -76.26%900.29K | -2.69%1.29M | 2.77%2.2M | 42.55%3.46M | 102.52%2.43M | 415.50%3.79M | 10.74%1.32M | 7.44%2.15M |
| Current changes in cash | 32.69%-845.14K | -254.86%-1.6M | 388.71%960.36K | -115.74%-388.53K | -11.58%-915.83K | -345.03%-1.26M | -15.94%1.03M | -119.66%-332.64K | 636.31%2.47M | -2.51%-820.75K |
| End cash Position | -53.94%1.02M | -46.23%1.86M | -46.23%1.86M | -76.26%900.29K | -2.69%1.29M | 2.77%2.2M | 42.55%3.46M | 42.55%3.46M | 415.50%3.79M | 10.74%1.32M |
| Free cash from | 52.91%-288.13K | -39.98%-2.07M | -919.53%-743.99K | 56.84%-258.11K | 23.87%-459.97K | -65.35%-611.91K | -2.25%-1.48M | 134.23%90.78K | -111.38%-598.09K | -17.31%-604.21K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.